• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·300239.SZ
Share

Baotou Dongbao Bio-Tech Co.,Ltd Stocks

CN¥ 5.12Last Updated 13.07.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 460.81M

CN¥ 5.12
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Baotou Dongbao Bio-Tech Co., Ltd. specializes in the research, manufacturing, and global sales of gelatin and collagen products, serving both domestic and international markets. Their offerings include gelatin for food additives and pharmaceutical applications, as well as collagen peptides. The company was founded in 1997 and is headquartered in Baotou, People's Republic of China.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.07.2026 16:04

"Records Across the Board": JPMorgan Reports a 41% Increase in Quarterly Profit

14.07.2026 15:48

Morning in New York: News Flow Will Drive Volatility

14.07.2026 14:41

Shares of a small-cap AI solutions developer soared amid a sector-wide slump. Why?

14.07.2026 13:30

Risks for a neobank: Can Revolut Reach a $200 Billion Valuation?

14.07.2026 12:58

Following SK Hynix, Samsung has approved the listing of its securities in the U.S. — Bloomberg

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026